Next Article in Journal
Treatment Strategies for Glioblastoma in the Elderly: What Should We Focus on Compared to Younger Patients
Next Article in Special Issue
Therapeutic Implications of Targeting YY1 in Glioblastoma
Previous Article in Journal
Preliminary Experience with Virtual Monoenergetic Imaging and Iodine Mapping in the Primary Staging of Endometrial Cancer
Previous Article in Special Issue
Detecting Microsatellite Instability in Endometrial, Colon, and Stomach Cancers Using Targeted NGS
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 16
Issue 6
10.3390/cancers16061230
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Cancers 2020, 12(2), 447.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. Cancers 2020, 12, 447

by
Clemens Zwergel
1,2,†,
Rossella Fioravanti
1,†,
Giulia Stazi
1,
Federica Sarno
2,
Cecilia Battistelli
3,
Annalisa Romanelli
1,
Angela Nebbioso
2,
Eduarda Mendes
4,
Alexandra Paulo
4,
Raffaele Strippoli
3,5,
Marco Tripodi
3,5,6,
Dany Pechalrieu
7,
Paola B. Arimondo
7,8,
Teresa De Luca
9,
Donatella Del Bufalo
9,
Daniela Trisciuoglio
9,10,*,
Lucia Altucci
2,
Sergio Valente
1,* and
Antonello Mai
1,*
1
Department of Drug Chemistry and Technologies, Sapienza University of Rome, P. le A. Moro 5, 00185 Rome, Italy
2
Department of Precision Medicine, University of Studi della Campania Luigi Vanvitelli, Vico L. De Crecchio 7, 80138 Naples, Italy
3
Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy
4
Research Institute for Medicines, Medicinal Chemistry Group, Faculty of Pharmacy, Universidade de Lisboa, 1649 003 Lisbon, Portugal
5
National Institute for Infectious Diseases L. Spallanzani, IRCCS, Via Portuense, 292, 00149 Rome, Italy
6
Istituto Pasteur- Fondazione Cenci Bolognetti, Department of Molecular Medicine, Sapienza Università di Roma, 00185 Rome, Italy
7
ETaC CNRS FRE3600, LMBE, 118 route de Narbonne, 31062 Toulouse, France
8
Epigenetic Chemical Biology, Institute Pasteur, CNRS UMR3523, 28 rue du Docteur Roux, 75724 Paris, France
9
Preclinical Models and New Therapeutic Agents Unit, IRCCS-Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy
10
Institute of Molecular Biology and Pathology, National Research Council (CNR), Via Degli Apuli 4, 00185 Rome, Italy
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Cancers 2024, 16(6), 1230; https://doi.org/10.3390/cancers16061230
Submission received: 29 January 2024 / Accepted: 14 February 2024 / Published: 21 March 2024
(This article belongs to the Collection Targeting Solid Tumors)
Browse Figure
Versions Notes
In the original publication [1], there was a mistake in Figure 7 as published. Figure 7 contained a duplication of the DAC GFP image (up), taken from the corresponding DAC GFP image published in ref. [1]. As two manuscripts were written with a short time between them, this is the result of an error while copying/pasting the individual pictures used to prepare Figure 7 in this paper. The erroneous picture did not affect the corresponding quantification and the interpretation of the results as this was performed with the correct picture set. The corrected Figure 7 appears below.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Zwergel, C.; Fioravanti, R.; Stazi, G.; Sarno, F.; Battistelli, C.; Romanelli, A.; Nebbioso, A.; Mendes, E.; Paulo, A.; Strippoli, R.; et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. Cancers 2020, 12, 447. [Google Scholar] [CrossRef] [PubMed]
Cancers 16 01230 g007
Figure 7. Compounds 2a–c and 4a–c display DNA demethylating activity in human HCT116 colon cancer cells. DAPI (up, blue pictures), fluorescence imaging (up, green pictures) and FACS evaluation (down) of HCT116 cells transfected with methylated pUCHL1 vector and treated for five days with DMSO as a vehicle control (Ctr), with DAC (5 µM) and SGI-1027 (0.5 µM) as reference compounds, and with 2a,b and 4a–c used at 0.5 µM, and 2c used at 0.1 µM.
Figure 7. Compounds 2a–c and 4a–c display DNA demethylating activity in human HCT116 colon cancer cells. DAPI (up, blue pictures), fluorescence imaging (up, green pictures) and FACS evaluation (down) of HCT116 cells transfected with methylated pUCHL1 vector and treated for five days with DMSO as a vehicle control (Ctr), with DAC (5 µM) and SGI-1027 (0.5 µM) as reference compounds, and with 2a,b and 4a–c used at 0.5 µM, and 2c used at 0.1 µM.
Cancers 16 01230 g007
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zwergel, C.; Fioravanti, R.; Stazi, G.; Sarno, F.; Battistelli, C.; Romanelli, A.; Nebbioso, A.; Mendes, E.; Paulo, A.; Strippoli, R.; et al. Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. Cancers 2020, 12, 447. Cancers 2024, 16, 1230. https://doi.org/10.3390/cancers16061230

AMA Style

Zwergel C, Fioravanti R, Stazi G, Sarno F, Battistelli C, Romanelli A, Nebbioso A, Mendes E, Paulo A, Strippoli R, et al. Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. Cancers 2020, 12, 447. Cancers. 2024; 16(6):1230. https://doi.org/10.3390/cancers16061230

Chicago/Turabian Style

Zwergel, Clemens, Rossella Fioravanti, Giulia Stazi, Federica Sarno, Cecilia Battistelli, Annalisa Romanelli, Angela Nebbioso, Eduarda Mendes, Alexandra Paulo, Raffaele Strippoli, and et al. 2024. "Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. Cancers 2020, 12, 447" Cancers 16, no. 6: 1230. https://doi.org/10.3390/cancers16061230

APA Style

Zwergel, C., Fioravanti, R., Stazi, G., Sarno, F., Battistelli, C., Romanelli, A., Nebbioso, A., Mendes, E., Paulo, A., Strippoli, R., Tripodi, M., Pechalrieu, D., Arimondo, P. B., De Luca, T., Del Bufalo, D., Trisciuoglio, D., Altucci, L., Valente, S., & Mai, A. (2024). Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. Cancers 2020, 12, 447. Cancers, 16(6), 1230. https://doi.org/10.3390/cancers16061230

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop